145 related articles for article (PubMed ID: 1697740)
1. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus.
Schinazi RF; Chu CK; Babu JR; Oswald BJ; Saalmann V; Cannon DL; Eriksson BF; Nasr M
Antiviral Res; 1990 May; 13(5):265-72. PubMed ID: 1697740
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
3. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
Montefiori DC; Zhou JY
Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
5. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase.
Higuchi H; Mori K; Kato A; Ohkuma T; Endo T; Kaji H; Kaji A
Antiviral Res; 1991; 15(3):205-16. PubMed ID: 1716088
[TBL] [Abstract][Full Text] [Related]
7. Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs.
Huang L; Kashiwada Y; Cosentino LM; Fan S; Chen CH; McPhail AT; Fujioka T; Mihashi K; Lee KH
J Med Chem; 1994 Nov; 37(23):3947-55. PubMed ID: 7525962
[TBL] [Abstract][Full Text] [Related]
8. The effect of trimeric 2',5'-oligoadenylic acid and its epoxy-derivative on human immunodeficiency virus (HIV-1) reproduction and retroviruses reverse transcriptase activity.
Tkachuk ZYu ; Rybalko SL; Semernikova LI; Tkachuk VV; Zavelevich MP; Tkachuk LV; Eremenko T; Mikhailopulo IA; Matsuka GK
New Microbiol; 1998 Apr; 21(2):197-201. PubMed ID: 9579344
[TBL] [Abstract][Full Text] [Related]
9. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
Li P; Kuiper LJ; Stephenson AJ; Burrell CJ
J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883
[TBL] [Abstract][Full Text] [Related]
10. Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.
Kleim JP; Bender R; Billhardt UM; Meichsner C; Riess G; Rösner M; Winkler I; Paessens A
Antimicrob Agents Chemother; 1993 Aug; 37(8):1659-64. PubMed ID: 7692812
[TBL] [Abstract][Full Text] [Related]
11. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
Mohan P; Singh R; Baba M
Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
[TBL] [Abstract][Full Text] [Related]
12. [Studies on synthesis and anti-HIV RT activity of hypericin and ethylhypericin].
Zhao J; Zhang Z; Chen H; Chen X
Yao Xue Xue Bao; 1998; 33(1):67-71. PubMed ID: 11938940
[TBL] [Abstract][Full Text] [Related]
13. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
14. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development.
de Clercq E
Med Res Rev; 1996 Mar; 16(2):125-57. PubMed ID: 8656777
[No Abstract] [Full Text] [Related]
16. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation.
Lenard J; Rabson A; Vanderoef R
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):158-62. PubMed ID: 7678335
[TBL] [Abstract][Full Text] [Related]
17. Modification of human immunodeficiency viral replication by pine cone extracts.
Lai PK; Donovan J; Takayama H; Sakagami H; Tanaka A; Konno K; Nonoyama M
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):205-17. PubMed ID: 1691654
[TBL] [Abstract][Full Text] [Related]
18. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives.
Andersen DO; Weber ND; Wood SG; Hughes BG; Murray BK; North JA
Antiviral Res; 1991 Sep; 16(2):185-96. PubMed ID: 1665961
[TBL] [Abstract][Full Text] [Related]
19. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells.
Nonaka G; Nishioka I; Nishizawa M; Yamagishi T; Kashiwada Y; Dutschman GE; Bodner AJ; Kilkuskie RE; Cheng YC; Lee KH
J Nat Prod; 1990; 53(3):587-95. PubMed ID: 1698933
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
Vonsover A; Loya S; Sredni B; Albeck M; Gotlieb-Stematsky T; Araf O; Hizi A
AIDS Res Hum Retroviruses; 1992 May; 8(5):613-23. PubMed ID: 1381205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
